A trial for potential treatments targeting the Ebola virus responsible for the current outbreak in the Democratic Republic of Congo has commenced, as announced by the World Health Organization (WHO). The first patient has been enrolled in the trial, which follows reports of over 1,400 cases and 438 deaths related to the outbreak, according to WHO chief Tedros Adhanom Ghebreyesus.

Residents in eastern Congo are hopeful as a new clinical trial for Ebola treatments has commenced at the Evangelical Medical Center in Bunia. Researchers are testing two experimental treatments in response to the ongoing Ebola outbreak in the region, aiming to combat the disease's spread.

According to the World Health Organization, the Democratic Republic of the Congo (DRC) has reported 1,460 confirmed Ebola cases and 432 deaths as of Wednesday, marking the highest level of new cases since the outbreak began. The case fatality rate stands at approximately 31 percent, with cases recorded across 36 health zones in three provinces.

The Democratic Republic of the Congo (DRC) has reported over 1,000 confirmed cases of Ebola, with the total reaching 1,003, including 254 deaths, according to the DRC Health Ministry. The outbreak is still active and has not yet peaked, indicating ongoing concerns regarding the spread of the virus.

France has confirmed its first case of Ebola, amid an ongoing outbreak in the Democratic Republic of Congo, where over 260 deaths have been reported. The situation highlights the continuing threat posed by the virus in the region.

Uganda has reported a new positive case of Ebola, nearly three weeks after the last recorded case on June 5, 2026. This new case increases the total number of Ebola cases in the country to twenty, according to sources within the Ministry of Health. The confirmation of the case occurred on Monday.